Star Equity Correlations
STRR Stock | USD 3.04 0.24 8.57% |
The current 90-days correlation between Star Equity Holdings and Biodesix is 0.2 (i.e., Modest diversification). The correlation of Star Equity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Star Equity Correlation With Market
Good diversification
The correlation between Star Equity Holdings and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Star Equity Holdings and DJI in the same portfolio, assuming nothing else is changed.
Star |
Moving together with Star Stock
0.83 | HLN | Haleon plc | PairCorr |
0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.9 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.88 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.91 | RDY | Dr Reddys Laboratories | PairCorr |
0.9 | TAK | Takeda Pharmaceutical | PairCorr |
0.77 | ZTS | Zoetis Inc | PairCorr |
0.73 | LTRN | Lantern Pharma | PairCorr |
0.67 | ABBV | AbbVie Inc | PairCorr |
0.86 | AMGN | Amgen Inc | PairCorr |
0.77 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.78 | ANRO | Alto Neuroscience, | PairCorr |
0.61 | TEVA | Teva Pharma Industries Sell-off Trend | PairCorr |
Moving against Star Stock
0.87 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.84 | ESPR | Esperion Therapeutics | PairCorr |
0.83 | VTRS | Viatris | PairCorr |
0.71 | GILD | Gilead Sciences | PairCorr |
0.6 | BFRIW | Biofrontera Warrants | PairCorr |
0.57 | WAT | Waters | PairCorr |
0.54 | EWTX | Edgewise Therapeutics | PairCorr |
0.5 | EBS | Emergent Biosolutions | PairCorr |
0.44 | BHC | Bausch Health Companies | PairCorr |
0.79 | BSX | Boston Scientific Corp | PairCorr |
0.77 | MNMD | Mind Medicine | PairCorr |
0.76 | DXCM | DexCom Inc | PairCorr |
0.6 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.58 | ABT | Abbott Laboratories Fiscal Year End 22nd of January 2025 | PairCorr |
0.39 | EW | Edwards Lifesciences Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Star Stock performing well and Star Equity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Star Equity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
VNRX | 4.18 | 0.10 | 0.01 | 0.32 | 4.88 | 9.38 | 32.29 | |||
LMDX | 4.74 | (0.96) | 0.00 | (0.64) | 0.00 | 11.54 | 34.05 | |||
GTH | 1.87 | 0.03 | (0.03) | (0.30) | 2.49 | 3.45 | 14.43 | |||
BDSX | 2.60 | (0.29) | 0.00 | 4.26 | 0.00 | 5.95 | 29.48 | |||
FONR | 1.49 | (0.15) | 0.00 | (0.10) | 0.00 | 2.15 | 10.60 | |||
BNR | 5.38 | (0.03) | 0.01 | 0.10 | 7.90 | 15.95 | 46.14 | |||
SERA | 3.84 | (0.36) | 0.00 | (0.01) | 0.00 | 9.55 | 27.67 | |||
OLK | 0.63 | 0.13 | 0.07 | 0.50 | 0.48 | 1.58 | 4.37 | |||
STIM | 5.11 | 0.11 | 0.03 | 0.16 | 7.39 | 8.99 | 59.07 |
Star Equity Corporate Management
Jeffrey Eberwein | Executive Board | Profile | |
Bob Halbert | Director Resource | Profile | |
Martin Shirley | Pres Solutions | Profile | |
Matthew Molchan | I Health | Profile | |
CCP CEBS | Senior Resource | Profile | |
Hannah Bible | Chief Officer | Profile | |
Scott Jarchow | I EdgeBuilder | Profile |